[{"id":"2bd8d7e3-2866-4404-8168-221feade23c7","acronym":"JIVAN","url":"https://clinicaltrials.gov/study/NCT05861947","created_at":"2024-01-31T23:19:25.849Z","updated_at":"2024-07-02T16:35:21.457Z","phase":"Phase 1","brief_title":"A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies","source_id_and_acronym":"NCT05861947 - JIVAN","lead_sponsor":"Aurigene Discovery Technologies Limited","biomarkers":" CD8 • IFNG • IL6 • CD4 • IL2 • NCAM1","pipe":"","alterations":" ","tags":["CD8 • IFNG • IL6 • CD4 • IL2 • NCAM1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AUR-106"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 08/26/2023","start_date":" 08/26/2023","primary_txt":" Primary completion: 05/01/2025","primary_completion_date":" 05/01/2025","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2024-01-31"}]